Canlyniadau Chwilio - Wechalekar, Ashutosh

The Evolving Epidemiology of Amyloidosis gan Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Update on treatment of light chain amyloidosis gan Mahmood, Shameem, Palladini, Giovanni, Sanchorawala, Vaishali, Wechalekar, Ashutosh

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Thoracic amyloidomas: Two case reports of an evasive diagnosis gan Cresner, Rosie, Mahmood, Shameem, Chen, Jane, Rowan, Camilla, Wechalekar, Ashutosh D

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Updates in Cardiac Amyloidosis: A Review gan Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

[(18)F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström’s Macroglobulinemia gan Fox, Thomas A., Lunn, Michael, Wechalekar, Ashutosh, Bomanji, Jamshed, Wan, Simon, D’Sa, Shirley

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c... gan Wechalekar, Ashutosh D., Gillmore, Julian D., Wassef, Nancy, Lachmann, Helen J., Whelan, Carol, Hawkins, Philip N.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds gan Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Two types of amyloid in a single heart gan Mahmood, Shameem, Gilbertson, Janet A., Rendell, Nigel, Whelan, Carol J., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study gan Banypersad, Sanjay M, Fontana, Marianna, Maestrini, Viviana, Sado, Daniel, White, Steven K, Treibel, Thomas A, Lachmann, Helen, Wechalekar, Ashutosh, Hawkins, Philip N, Moon, James

Cael y testun llawn Cael y testun llawn

Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis gan Gillmore, Julian D., Lachmann, Helen J., Rowczenio, Dorota, Gilbertson, Janet A., Zeng, Cai-Hong, Liu, Zhi-Hong, Li, Lei-Shi, Wechalekar, Ashutosh, Hawkins, Philip N.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis gan Sharpley, Faye A., Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Fontana, Marianna, Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis gan Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Deferred autologous stem cell transplantation in systemic AL amyloidosis gan Manwani, Richa, Hegenbart, Ute, Mahmood, Shameem, Sachchithanantham, Sajitha, Kyriakou, Charalampia, Yong, Kwee, Popat, Rakesh, Rabin, Neil, Whelan, Carol, Dittrich, Tobias, Kimmich, Christoph, Hawkins, Philip, Schönland, Stefan, Wechalekar, Ashutosh

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria gan Sharpley, Faye A., Fontana, Marianna, Martinez-Naharro, Ana, Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic gan Kastritis, Efstathios, Wechalekar, Ashutosh, Schönland, Stefan, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Minnema, Monique, Roussel, Murielle, Jaccard, Arnaud, Hegenbart, Ute, Kumar, Shaji, Cibeira, Maria T., Blade, Joan, Dimopoulos, Meletios A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis gan Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis gan Dungu, Jason, Whelan, Carol J, Gibbs, Simon D, Pinney, Jennifer H, Banypersad, Sanjay M, Venner, Christopher P, Lachmann, Helen J, Wechalekar, Ashutosh, Gillmore, Julian D, Hawkins, Philip N, Anderson, Lisa

Cael y testun llawn Cael y testun llawn

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis gan Manwani, Richa, Foard, Darren, Mahmood, Shameem, Sachchithanantham, Sajitha, Lane, Thirusha, Quarta, Cristina, Youngstein, Taryn, Rezk, Tamer, Lachmann, Helen J, Gillmore, Julian D., Fontana, Marianna, Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib gan Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis gan Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D

Cael y testun llawn Cael y testun llawn Cael y testun llawn